Protein expression, survival and docetaxel benefit in node-positive breast cancer treated with adjuvant chemotherapy in the FNCLCC - PACS 01 randomized trial

INTRODUCTION: The PACS01 trial has demonstrated that a docetaxel addition to adjuvant anthracycline-based chemotherapy improves disease-free survival (DFS) and overall survival of node-positive early breast cancer (EBC). We searched for prognostic and predictive markers for docetaxel's benefit....

Descripción completa

Detalles Bibliográficos
Autores principales: Jacquemier, Jocelyne, Boher, Jean-Marie, Roche, Henri, Esterni, Benjamin, Serin, Daniel, Kerbrat, Pierre, Andre, Fabrice, Finetti, Pascal, Charafe-Jauffret, Emmanuelle, Martin, Anne-Laure, Campone, Mario, Viens, Patrice, Birnbaum, Daniel, Penault-Llorca, Frédérique, Bertucci, François
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3326551/
https://www.ncbi.nlm.nih.gov/pubmed/22044691
http://dx.doi.org/10.1186/bcr3051

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3326551/
https://www.ncbi.nlm.nih.gov/pubmed/22044691
http://dx.doi.org/10.1186/bcr3051

Ejemplares similares